How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

349 results for

Community Acquired Pneumonia Refractory to Standard Management

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Community Acquired Pneumonia Refractory to Standard Management

Community Acquired Pneumonia Refractory to Standard Management Community Acquired Pneumonia Refractory to Standard Management Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure (...) Miscellaneous Abuse Cancer Administration 4 Community Acquired Pneumonia Refractory to Standard Management Community Acquired Pneumonia Refractory to Standard Management Aka: Community Acquired Pneumonia Refractory to Standard Management From Related Chapters II. Indications No improvement after 72 hours of antibiotics for community acquired III. Causes resistant to current antibiotic spectrum See Empyema or Nosocomial superinfection Non-infectious cause of or other respiratory symptoms organizing Secondary

2018 FP Notebook

2. Community Acquired Pneumonia Refractory to Standard Management

Community Acquired Pneumonia Refractory to Standard Management Community Acquired Pneumonia Refractory to Standard Management Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure (...) Miscellaneous Abuse Cancer Administration 4 Community Acquired Pneumonia Refractory to Standard Management Community Acquired Pneumonia Refractory to Standard Management Aka: Community Acquired Pneumonia Refractory to Standard Management From Related Chapters II. Indications No improvement after 72 hours of antibiotics for community acquired III. Causes resistant to current antibiotic spectrum See Empyema or Nosocomial superinfection Non-infectious cause of or other respiratory symptoms organizing Secondary

2015 FP Notebook

3. The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age Full Text available with Trip Pro

The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America (...) | Clinical Infectious Diseases | Oxford Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close mobile search navigation Article navigation 1 October 2011 Article Contents Article Navigation The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America John S

2011 Infectious Diseases Society of America

4. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic Full Text available with Trip Pro

of date? To get the best experience using our website we recommend that you upgrade to a newer version. . COVID-19 and Cardiology ESC sub specialties communities Search Read your latest personalised notifications No account yet? Don't miss out Read your latest personalised notifications Loading quicklinks... ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic Last updated on 21 April 2020 1. Introduction Severe acute respiratory syndrome coronavirus 2 ( ) causing (...) ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser. Did you know that your browser is out

2020 European Society of Cardiology

5. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)

with Staphylococcus aureus is common with in?uenza pneumonia and can be especially virulent [154]. Recent clinical practice guidelines recommend initiating empiric antibacterial therapy in adults with community-acquired pneumonia who test positive for in?uenza [154]. Data from critically ill patients demonstrate secondary infection in about 11% of cases, although the numbers are small. Isolated organisms included gram-negative Intensive Care Medicine GUIDELINES Un-edited accepted proof* © European Society (...) in this population and may to lead to a substantial increase in mortality, as in pandemic influenza [156-158]. Therefore, critically ill patients with suspected or confirmed COVID-19 should be treated with empiric antimicrobial therapy in accordance with the clinical syndrome (e.g., community-acquired or hospital-acquired pneumonia). Secondary infections occur in patients with COVID-19, but the incidence is unknown given the very limited data [159]. These infections should be treated according to clinical

2020 Covid-19 Ad hoc guidelines

6. Diagnosis and Management of Acute Pulmonary Embolism Full Text available with Trip Pro

Diagnosis and Management of Acute Pulmonary Embolism 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) | European Heart Journal | Oxford Academic ') We use cookies to enhance your experience on our website.By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Search Account Menu Menu Navbar Search Filter Mobile Microsite (...) Search Term Close search filter search input Article Navigation Close mobile search navigation Article Navigation Article Contents Article Navigation 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) Stavros V Konstantinides Chairperson Germany/Greece Corresponding authors: Stavros

2019 European Society of Cardiology

7. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children Full Text available with Trip Pro

is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website ( ). Drs. Weiss and Peters served as arbiters for conflict interest management and adjudication throughout the guidelines process following standard operating procedures set forth by Society of Critical Care Medicine (SCCM) and endorsed by European Society of Intensive Care Medicine. Dr. Weiss participates in Pediatric Acute Lung Injury (...) factors, and geographic location ( , , ). The majority of children who die of sepsis suffer from refractory shock and/or multiple organ dysfunction syndrome, with many deaths occurring within the initial 48 to 72 hours of treatment ( ). Early identification and appropriate resuscitation and management are therefore critical to optimizing outcomes for children with sepsis . In 2001, the Surviving Sepsis Campaign (SSC) was formed by the Society of Critical Care Medicine (SCCM), European Society

2020 Society of Critical Care Medicine

8. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 Last updated April 13, 2020 at 9:06 AM EDT and posted online at www.idsociety.org/COVID19guidelines. Please check website for most updated version of these guidelines. Version 1.0.1 Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 Authors Adarsh Bhimraj 1 , Rebecca L. Morgan 2 , Amy Hirsch Shumaker 3 , Valery Lavergne 4 , Lindsey (...) -19. There is a need for frequently updated practice guidelines on their use, based on critical evaluation of rapidly emerging literature. Objective: Develop evidence-based rapid guidelines intended to support patients, clinicians and other health-care professionals in their decisions about treatment and management of patients with COVID-19. Methods: IDSA formed a multidisciplinary guideline panel of infectious disease clinicians, pharmacists, and methodologists with varied areas of expertise

2020 Infectious Diseases Society of America

9. Management of Cardiovascular Diseases during Pregnancy Full Text available with Trip Pro

Management of Cardiovascular Diseases during Pregnancy We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy | European Heart Journal | Oxford Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close (...) mobile search navigation Article navigation 07 September 2018 Article Contents Article Navigation 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy Vera Regitz-Zagrosek Chairperson Corresponding authors. Vera Regitz-Zagrosek, Charité Universitaetsmedizin Berlin, Institute for Gender in Medicine, CCR, DZHK, partner site Berlin, Hessische Str 3-4, 10115 Berlin, Germany, Tel: +49 30 450 525 288, Fax: +49 30 450 7 525 288, E-mail: . Search for other works by this author

2018 European Society of Cardiology

10. Management of Decompensated Cirrhosis

) represent the ?rst CPGs on the management of decompensated cirrhosis. In this context, the panel of experts, having empha- sised the importance of initiating aetiologic treatment for any degreeofhepaticdiseaseattheearliestpossiblestage,extended its work to all the complications of cirrhosis, which had not been covered by the European Association for the Study of the Liver guidelines, namely: ascites, refractory ascites, hypona- tremia, gastrointestinal bleeding, bacterial infections, acute kid- ney (...) injury, hepatorenal syndrome, acute-on-chronic liver failure, relative adrenal failure, cirrhotic cardiomyopathy, hep- atopulmonary syndrome, and porto-pulmonary hypertension. The panel of experts, produced these GPGs using evidence from PubMed and Cochrane database searches providing up to date guidance on the management of decompensated cirrhosis with the only purpose of improving clinical practice. 2018EuropeanAssociationfortheStudyoftheLiver.Publishedby Elsevier B.V. All rights reserved

2018 European Association for the Study of the Liver

11. Management of Heart Failure (4th Edition)

Management of Heart Failure (4th Edition) MOH/P/PAK/421.19(GU)-ePUBLISHED BY: National Heart Association of Malaysia D-13A-06, Menara SUEZCAP 1, KL Gateway No.2 Jalan Kerinchi, Gerbang Kerinchi Lestari 59200 Kuala Lumpur eISBN 978-967-11794-4-4 COPYRIGHT The owners of this publication are the National Heart Association of Malaysia (NHAM) and the Academy of Medicine Malaysia. The content in this document may be produced in any number of copies and in any format or medium provided (...) to these guidelines may not necessarily guarantee the best outcome in every case. Every healthcare provider is responsible for the management of his/her patient based on the clinical picture presented by the patient and the management options available locally. This CPG was issued in 2019 and will be reviewed in 5 years or sooner if new evidence becomes available. CPG Secretariat c/o Health Technology Assessment Unit Medical Development Division Ministry of Health Malaysia 4th Floor,Block E1, Parcel E 62590

2019 Ministry of Health, Malaysia

12. Sepsis Management

Clinical Audit so as to recommend them to the Minister for Health to become part of a suite of National Clinical Guidelines and National Clinical Audit. National Clinical Guidelines which have been quality assured and recommended by NCEC for implementation provide robust evidence-based approaches to underpin or define models of care as appropriate. They provide guidance and standards for improving the quality, safety and cost-effectiveness of healthcare in Ireland. The implementation of clinical (...) to assist healthcare staff in the identification and management of patients with sepsis. A summary version of the National Clinical Guideline outlining the key recommendations, is available at: www.health.gov.ie/patient-safety/ncec The recommendations align with the aims of the national sepsis work stream. Key recommendations are linked with other recommendations, practical guidance, roles, responsibilities and processes. The recommendations are linked to the best available evidence and/or expert

2019 National Clinical Guidelines (Ireland)

13. 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza Full Text available with Trip Pro

%) and specificity (47%) among children aged <5 years [30]. In another prospective study among pediatric outpatients aged ≤13 years with respiratory infections, fever was the only reliable predictor of culture-confirmed influenza virus infection [40]. Influenza is an important cause of community-acquired pneumonia in adults [41]. Invasive bacterial coinfection may occur (with Staphylococcus aureus , Streptococcus pneumoniae , Streptococcus pyogenes [group A streptococci], and others) [42–45]. Secondary bacterial (...) . Recommendations (Abridged) Diagnosis I. Which patients should be tested for influenza? Outpatients (Including Emergency Department Patients) During influenza activity (defined as the circulation of seasonal influenza A and B viruses among persons in the local community) (see Figure 1): Clinicians should test for influenza in high-risk patients, including immunocompromised persons who present with influenza-like illness, pneumonia, or nonspecific respiratory illness (eg, cough without fever) if the testing

2019 Infectious Diseases Society of America

14. Guidelines on the Management of Acute Respiratory Distress Syndrome (ARDS)

of Critical Care 2008;23:101-10. 125. Chan MC, Hsu JY, Liu HH, et al. Effects of prone position on inflammatory markers in patients with ARDS due to community-acquired pneumonia. Journal of the Formosan Medical Association 2007;106:708- 16. 126. Guerin C, Gaillard S, Lemasson S, et al. Effects of systematic prone positioning in hypoxemic acute respiratory failure: A randomized controlled trial. Journal of the American Medical Association 2004;292:2379-87. 54 127. Mancebo J, Fernandez R, Blanch L, et al (...) TECHNICAL SUMMARY The guidelines for the management of adult patients with ARDS were created by a multi-disciplinary writing group constituted by the Joint Standards Committee of the Faculty of Intensive Care Medicine (FICM) and the Intensive Care Society (ICS). All group members, including lay members, are co-authors of the guideline. The group first met in 2013 and completed the guidelines in 2018. The guidelines have undergone both independent external peer review and also input from stakeholder

2018 Faculty of Intensive Care Medicine

15. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy Full Text available with Trip Pro

of Washington, and the Fred Hutchinson Cancer Research Center, Seattle, WA; and Tanyanika Phillips, CHRISTUS St Frances Cabrini Cancer Center, Alexandria, LA. Abstract Section: Purpose To increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events in patients treated with immune checkpoint inhibitor (ICPi) therapy. Methods A multidisciplinary, multi-organizational panel of experts in medical oncology, dermatology, gastroenterology, rheumatology (...) (irAEs) with close monitoring. However, moderate to severe irAEs may be associated with severe declines in organ function and quality of life, and fatal outcomes have been reported; hence, these toxicities require early detection and proper management. Use of ICPis in patients with preexisting autoimmune disease or history of prior organ transplant requires an especially thoughtful discussion of potential risks and benefits. In recognition of an increasing need for guidance, ASCO and the National

2018 American Society of Clinical Oncology Guidelines

16. European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas Full Text available with Trip Pro

Society of Endocrinology has initiated this guideline on the Management of Aggressive Pituitary DOI: Page(s): G1–G24 Volume/Issue: Article Type: Research Article Online Publication Date: Jan 2018 Copyright: © 2018 European Society of Endocrinology 2018 Free access Background Pituitary tumours are common and easily treated by surgery or medical treatment in most cases. However, a small subset of pituitary tumours does not respond to standard medical treatment and presents with multiple local (...) used as backbone for the guideline. Selected recommendation (i) Patients with aggressive pituitary tumours should be managed by a multidisciplinary expert team. (ii) Histopathological analyses including pituitary hormones and proliferative markers are needed for correct tumour classification. (iii) Temozolomide monotherapy is the first-line chemotherapy for aggressive pituitary tumours and pituitary carcinomas after failure of standard therapies; treatment evaluation after 3 cycles allows

2018 European Society of Endocrinology

17. Gastro-oesophageal reflux disease in children and young people: diagnosis and management

Gastro-oesophageal reflux disease in children and young people: diagnosis and management Gastro-oesophageal reflux disease in Gastro-oesophageal reflux disease in children and y children and young people: diagnosis and oung people: diagnosis and management management NICE guideline Published: 14 January 2015 nice.org.uk/guidance/ng1 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our (...) and managed according to the best practice guidance described in the Department of Health's Transition: getting it right for young people. Adult and paediatric healthcare teams should work jointly to provide assessment and services to young people with GORD. Diagnosis and management should be reviewed throughout the transition process, and there should be clarity about who is the lead clinician to ensure continuity of care. Gastro-oesophageal reflux disease in children and young people: diagnosis

2015 National Institute for Health and Clinical Excellence - Clinical Guidelines

18. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications

applications in non-CDI settings. The key clinical stakeholders for the provision and governance of FMT services in the UK have tended to be in two major specialty areas: gastroenterology and microbiology/ infectious diseases. While the National Institute for Health and Care Excellence (NICE) guidance (2014) for use of FMT for recurrent or refractory CDI has become accepted in the UK, clear evidence-based UK guidelines for FMT have been lacking. This resulted in discussions between the British Society (...) or refractory CDI, but non-CDI indica- tions are also considered. These guidelines only apply to adult patients (=18 years); the working party did not consider the role of FMT in the treatment of either CDI or non-CDI indications in children or young people. The guidelines were written with a focus on UK practice, but also with consideration of more global practice as it applied. The diagnosis and management of CDI in general are outside the remit of these guidelines. 4.3. Evidence appraisal Questions

2018 British Society of Gastroenterology

19. BSR guideline Management of Adults with Primary Sjögren's Syndrome Full Text available with Trip Pro

Standards, Guideline and Audit Working Group, The British Society for Rheumatology guideline for the management of adults with primary Sjögren’s Syndrome, Rheumatology , Volume 56, Issue 10, October 2017, Pages e24–e48, Download citation file: © 2019 Oxford University Press Navbar Search Filter Mobile Microsite Search Term Close search filter search input , , , Background Primary Sjogren's Syndrome (pSS) is a classic, immune-mediated, condition of unknown aetiology characterized by focal lymphocytic (...) accredited the process used by the BSR to produce its guidance for the management of primary Sjögren's Syndrome in adults. Accreditation is valid for 5 years from 10 June 2013. More information on accreditation can be viewed at . For full details on our accreditation visit: . This guideline reviews the treatment of the glandular and systemic features of pSS The management of the glandular features includes conserving, replacing and stimulating secretions. Systemic features may require system-specific

2017 British Society for Rheumatology

20. Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association Full Text available with Trip Pro

successfully implemented. , , , In Arizona, hospital bypass by emergency medical services to designated OHCA centers equipped to provide best-practice in-hospital care was associated with improved overall survival from 8.9% to 14.4%. The management of STEMI represents the paradigm for integrated systems of care with coordinated emergency medical services, community, and tertiary care centers, coupled with standardized hub-and-spoke transfer protocols, quality assurance, real-time feedback, and healthcare (...) . Regional protocols should standardize management practices, provide futility parameters, and determine the timing of transfer once the diagnosis of refractory CS is established. Figure 3. Proposed regional system of care for cardiogenic shock. ( A ) A patient with CS diagnosed in the field by EMS can be transported directly to the hub CS center, bypassing the nearest spoke facility. ( B ) CS pathogenesis, travel time, and spoke center capabilities should factor into the decision to bypass spoke

2017 American Heart Association

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>